valproic acid has been researched along with fibrinogen in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (36.84) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lodish, JR; Neophytides, AN; Nutt, JG | 1 |
| Göbel, U; Schulte-Berbühl, R; von Voss, H | 1 |
| McLain, LW; Sussman, NM | 1 |
| Green, PJ; Majer, RV | 1 |
| Berkovic, SF; Bladin, PF; Jones, DB; Smallwood, RA; Vajda, FJ | 1 |
| Beran, RG; Read, T; Reid, M; Rischbieth, RH; Sansom, L; Schapel, GJ; Stanley, PE | 1 |
| Ehrenthal, W; Rochel, M | 1 |
| Breningstall, GN; Cich, JA | 1 |
| Balasa, V; Degrauw, A; Fogelson, H; Gartside, P; Glauser, T; Gruppo, R | 1 |
| Anderson, GD; Chandler, WL; Temkin, NR; Winn, HR | 1 |
| Ugras, M; Yakinci, C | 1 |
| Fujihara, N; Hirota-Kawadobora, M; Ishikawa, S; Kamijo, Y; Katsuyama, T; Okumura, N; Terasawa, F; Wakabayashi, S; Yamauchi, K | 1 |
| Dempfle, CE; Gerstner, T; Keller, A; Koenig, S; Longin, E; Teich, M | 1 |
| Akar, N; Deda, G; Ertem, M; Teber, S; Unal, O | 1 |
| Arhan, E; Guven, A; Köse, G; Ozaydin, E; Sayli, TR; Unal, B | 1 |
| Friebel, D; Gehrisch, S; Knöfler, R; Kuhlisch, E; Schädlich, D; Schallner, J; Siegert, G | 1 |
| Lischetzki, G; Rascher, W; Rauh, M; Topf, HG; Trollmann, R | 1 |
| Cassidy, MR; Gainsbury, ML; Heydrick, S; Sheldon, HK; Sherburne, AC; Stucchi, AF | 1 |
| Cassidy, MR; Heydrick, SJ; Sherburne, AC; Stucchi, AF | 1 |
3 trial(s) available for valproic acid and fibrinogen
| Article | Year |
|---|---|
Individualized patient assessment in the treatment of epilepsy with sodium valproate.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Epilepsy; Female; Fibrinogen; Humans; Intelligence; Liver Function Tests; Male; Platelet Aggregation; Valproic Acid | 1980 |
Effect of valproate on hemostatic function in patients with traumatic brain injury.
Topics: Adult; Aged; Brain Injuries; Double-Blind Method; Female; Fibrinogen; Hemostasis; Humans; Male; Middle Aged; Platelet Count; Statistics, Nonparametric; Valproic Acid | 2003 |
High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
Topics: Anticonvulsants; Blood Platelets; Child; Child, Preschool; Factor XIII; Female; Fibrinogen; Humans; Male; Prospective Studies; Thrombelastography; Thrombocytopenia; Valproic Acid; von Willebrand Diseases; von Willebrand Factor | 2008 |
16 other study(ies) available for valproic acid and fibrinogen
| Article | Year |
|---|---|
Lowered erythrocyte-sedimentation rate with sodium valproate.
Topics: Adult; Afibrinogenemia; Blood Sedimentation; Fibrinogen; Humans; Movement Disorders; Valproic Acid | 1978 |
Side effects of sodium valproate (sodium di-N-propylacetate) on malonyldialdehyde-production and other platelet function tests.
Topics: Adult; Blood Platelet Disorders; Blood Platelets; Child; Epilepsy; Factor IX; Factor VIII; Fibrinogen; Humans; Malonates; Malondialdehyde; Prothrombin; Thrombin; Valproic Acid | 1978 |
A direct hepatotoxic effect of valproic acid.
Topics: Adolescent; Adult; Alkaline Phosphatase; Blood Coagulation Tests; Child; Dose-Response Relationship, Drug; Epilepsy; Female; Fibrinogen; Humans; L-Lactate Dehydrogenase; Liver; Male; Transaminases; Valproic Acid | 1979 |
Neonatal afibrinogenaemia due to sodium valproate.
Topics: Afibrinogenemia; Female; Fibrinogen; Humans; Infant, Newborn; Male; Valproic Acid | 1987 |
Hepatotoxicity of sodium valproate.
Topics: Adolescent; Adult; Aged; Carbamazepine; Chemical and Drug Induced Liver Injury; Child; Fibrinogen; gamma-Glutamyltransferase; Humans; Middle Aged; Phenytoin; Prospective Studies; Retrospective Studies; Valproic Acid | 1983 |
[Drug monitoring for valproic acid with HPLC or EMIT and concomitant measurements of clinical-chemical parameters (author's transl)].
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Chemistry, Clinical; Child; Child, Preschool; Chromatography, High Pressure Liquid; Fibrinogen; Humans; Immunoenzyme Techniques; Infant; Lipase; Partial Thromboplastin Time; Platelet Count; Prothrombin Time; Thrombin Time; Valproic Acid | 1982 |
Pseudo valproate-induced hypofibrinogenemia.
Topics: Afibrinogenemia; Anticonvulsants; Child; Fibrinogen; Humans; Male; Valproic Acid | 1996 |
Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke.
Topics: Anticonvulsants; Antithrombins; Child; Child, Preschool; Female; Fibrinogen; Humans; Infant; Platelet Count; Protein C; Protein C Deficiency; Protein S; Seizures; Stroke; Valproic Acid | 2000 |
Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
Topics: Adolescent; Anticoagulants; Anticonvulsants; Blood Cell Count; Case-Control Studies; Child; Child, Preschool; Enzyme Activation; Epilepsy; Female; Fibrinogen; Humans; Infant; Male; Protein C; Protein S; Retrospective Studies; Statistics, Nonparametric; Valproic Acid | 2006 |
[Analysis of hypofibrinogenemias found on routine coagulation screening tests and identification of heterozygous dysfibrinogenemia or fibrinogen deficiency].
Topics: Adrenocorticotropic Hormone; Afibrinogenemia; Asparaginase; Fibrinogen; Heterozygote; Humans; Infant; Spasms, Infantile; Thrombin Time; Valproic Acid | 2007 |
Thrombophilic risk factors in epileptic children treated with valproic Acid.
Topics: Adolescent; Anticonvulsants; Antithrombin III; Blood Coagulation Factors; Child; Child, Preschool; Epilepsy; Female; Fibrinogen; Homocysteine; Humans; Infant; Lipoprotein(a); Male; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia; Valproic Acid | 2009 |
Valproate-associated coagulopathies in children during short-term treatment.
Topics: Adolescent; Anticonvulsants; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Protein Disorders; Child; Child, Preschool; Down-Regulation; Drug Administration Schedule; Epilepsy; Factor VII; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Male; Platelet Count; Prospective Studies; Protein C; Valproic Acid | 2009 |
[Evaluation of haemostasis in children treated with valproic acid].
Topics: Adenosine Triphosphate; Anticonvulsants; Blood Coagulation; Child; Factor VIII; Factor XIII; Fibrinogen; Hemostasis; Humans; Platelet Aggregation; Thrombin; Valproic Acid | 2010 |
The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Fibrinogen; Humans; Infant; Male; Partial Thromboplastin Time; Platelet Count; Reference Values; Thrombelastography; Thrombin; Valproic Acid; Young Adult | 2011 |
Histone deacetylase inhibitors decrease intra-abdominal adhesions with one intraoperative dose by reducing peritoneal fibrin deposition pathways.
Topics: Animals; Benzamides; Fibrin; Fibrinogen; Histone Deacetylase Inhibitors; Hydroxamic Acids; Intestines; Intraoperative Care; Male; Peritoneum; Pyridines; Rats; Rats, Wistar; Thromboplastin; Tissue Adhesions; Valproic Acid; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vorinostat; Wound Healing | 2014 |
Combined intraoperative administration of a histone deacetylase inhibitor and a neurokinin-1 receptor antagonist synergistically reduces intra-abdominal adhesion formation in a rat model.
Topics: Abdomen; Animals; Disease Models, Animal; Drug Synergism; Fibrinogen; Histone Deacetylase Inhibitors; Intraoperative Care; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Wistar; Tissue Adhesions; Valproic Acid; Vascular Endothelial Growth Factor A; Wound Healing | 2015 |